Long-acting medication, Vyvanse, has received Health Canada approval for use in all age groups. Until now, it was officially approved for children only in Canada.
The starting dose is 20-30mg and the maximum Health Canada sanctioned dose for all ages is 60mg. CADDRA recommends off-label use of up to 60mg in children, up to 70mg in adolescents and adults.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.